Total public drug program spending overall and for high–drug-cost beneficiaries* in Canada (excluding Quebec and territories), 2016/17
| Province | Overall | High–drug-cost beneficiaries | ||||
|---|---|---|---|---|---|---|
| Total program spending, $ millions | Mean cost per beneficiary, $ | Total program spending, $ millions | % of program spending | Minimum cost threshold, $ | Mean cost per beneficiary, $ | |
| Overall | 8185.0 | 1570 | 3809.0 | 46.5 | 5291 | 14 610 |
| British Columbia | 1087.2 | 1473 | 586.6 | 54.0 | 5319 | 15 896 |
| Alberta | 773.3 | 1330 | 363.5 | 47.0 | 3791 | 12 502 |
| Saskatchewan | 316.7 | 1106 | 175.5 | 55.4 | 3940 | 12 253 |
| Manitoba | 320.8 | 2347 | 174.7 | 54.5 | 8567 | 25 560 |
| Ontario | 5126.3 | 1673 | 2242.6 | 43.7 | 5656 | 14 640 |
| New Brunswick | 210.9 | 1662 | 93.5 | 44.3 | 5408 | 14 744 |
| Nova Scotia | 187.0 | 1369 | 76.3 | 40.8 | 4065 | 11 175 |
| Prince Edward Island | 26.0 | 632 | 13.7 | 52.6 | 2282 | 6650 |
| Newfoundland and Labrador | 136.8 | 1326 | 56.0 | 41.0 | 4397 | 10 863 |
↵* Defined as the top 5% of beneficiaries based on annual costs.